LoginRegister
    Judge to reevaluate $80 million award in Monsanto cancer caseJudge to reevaluate $80 million award in Monsanto cancer case
    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs ParliamentDrugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister...
    Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcersZydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers
    Elbrit Life Sciences to expand production capacity with over Rs 13 crore investmentElbrit Life Sciences to expand production capacity with over Rs 13 crore investment
    Delhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacistsDelhi High Court directs Centre to provide partial list of OTC drugs to doctors, pharmacists
    Indian pharma industry to grow at 11-13 percent in FY2020, says rating agency IcraIndian pharma industry to grow at 11-13 percent in FY2020, says rating agency Icra
    Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer boardElizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board
    Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugsDelhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs
    NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; DetailsNPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details
    CDSCO Warning: Beware of hacking risk in Medtronic insulin pumpsCDSCO Warning: Beware of hacking risk in Medtronic insulin pumps
    Aurobindo Pharma pulled up by USFDA for repeated CGMP failuresAurobindo Pharma pulled up by USFDA for repeated CGMP failures
    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solutionLupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X